Nuveen’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Nuveen’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-99,101	Closed	-$1.56M	–	3327
2023 Q4	$1.56M	Buy	99,101 +9,843	+11%	+$94.8K	﹤0.01%	2521
2023 Q3	$692K	Hold	89,258	–	–	﹤0.01%	2724
2023 Q2	$886K	Buy	89,258 +48,747	+120%	+$390K	﹤0.01%	2709
2023 Q1	$235K	Sell	40,511 -14,310	-26%	-$124K	﹤0.01%	2962
2022 Q4	$435K	Sell	54,821 -16,555	-23%	-$71.1K	﹤0.01%	2917
2022 Q3	$226K	Sell	71,376 -860	-1%	-$5.38K	﹤0.01%	3099
2022 Q2	$414K	Sell	72,236 -7,917	-10%	-$61.8K	﹤0.01%	3060
2022 Q1	$1.2M	Buy	80,153 +36,398	+83%	+$572K	﹤0.01%	2741
2021 Q4	$935K	Sell	43,755 -2,166	-5%	-$55.9K	﹤0.01%	2884
2021 Q3	$1.36M	Buy	+45,921	New	+$1.56M	﹤0.01%	2851

Nuveen's ICVX Position: Q1 2024 in Review

Nuveen sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 99,101 shares — an estimated $1.56M sold.

Nuveen first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $1.56M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Nuveen reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Nuveen sold 99,101 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $1.56M.
Nuveen first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
Nuveen's Icosavax, Inc. Common Stock position peaked at $1.56M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.